Condition
Leukemia Acute Myeloid - AML clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Leukemia Acute Myeloid - AML clinical trials that are recruiting, at sites in 2 countries (most in France (1), China (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Personalized dosing of azacytidine for patients with blood cancers
This study is testing if adjusting the dose of azacytidine based on patients' genetic information can help people with blood cancers like acute myeloid leukemia and myelodysplastic syndromes get better results with fewer side effects.
-
Comparing Clifutinib to Salvage Chemotherapy for Relapsed FLT3-ITD AML
This study is testing whether Clifutinib can help Chinese adults with relapsed FLT3-mutated acute myeloid leukemia feel better and live longer compared to standard chemotherapy.
Related topics
Quick answers
How many Leukemia Acute Myeloid - AML clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in France (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.